Brought to you by:
VAM: SVS PAC donors to be recognized at VAM
The SVS Political Action Committee (PAC) is critically important for our voices to be heard in the places where policies that affect all of our practices are being made. The PAC’s role is one of advocacy and influence—to educate Congress…
MicroStent to treat PAD below the knee receives FDA breakthrough device designation
Micro Medical Solutions (MMS) recently revealed Food and Drug Administration (FDA) breakthrough device designation for its MicroStent vascular stent. This novel technology is designed to achieve and maintain vessel patency, enhance wound treatment and improve quality of life and blood…
#SVSTweetChat: Connecting to the online vascular community
With social media having such a prevalent presence today, it continues to play a significant role in connecting surgeons, prospective trainees and medical students throughout the vascular community. The Society for Vascular Surgery (SVS) Social Media Committee has launched its…
Registration to open for VAM 2021
Registration and housing are set to open in mid-May for the 2021 Vascular Annual Meeting (VAM), which takes place Aug. 18–21 in San Diego. Educational programming is ready to run across all four days, with exhibits open Thursday and Friday.…
Hitting the spot: EVAR for rAAA should be ‘treatment of choice’ in 2021
If the equipment and requisite skillset are available, and a patient’s anatomy is suitable, endovascular aneurysm repair (EVAR) for ruptured abdominal aortic aneurysms (rAAAs) “should be the treatment of choice in 2021 and beyond,” vascular titan Frank Veith, MD, argued…
Interventions associated with ‘poor’ two-year relief of intermittent claudication symptoms
Peripheral vascular interventions for intermittent claudication were linked to “poor” two-year relief of symptoms in the Vascular Quality Initiative (VQI) database, a new study published in the May issue of the Journal of Vascular Surgery (JVS) found. First-named author Jonathan…
Enrollment starts in postmarket studies of WavelinQ endoAVF system
Enrollment has begun and the first patients have been treated in the postmarket surveillance study, CONNECT-AV, of the WavelinQ (BD) endovascular arteriovenous fistula (endoAVF) system. CONNECT-AV is a prospective, single-arm, open-label study that will follow patients treated with WavelinQ (BD)…
Wearable device for AV fistula remote monitoring shows promise—but faces commercial challenges
A new wearable device designed to remotely monitor arteriovenous (AV) fistulae function in dialysis access patients uncovered promising data, leading one set of researchers to conclude the technology offers hope for improved care and lower costs among a challenging patient…
Upcoming webinars: May to feature exchanges on coding, employment
The Society for Vascular Surgery (SVS) Community Practice Committee will host two webinars in May designed to support members in community-practice settings. Members may register now for either or both. The Coding Webinar starts at 7 p.m. CDT on…
SAVS issues 2021–2022 officer line-up
The Southern Association for Vascular Surgery (SAVS) has announced its officer slate for 2021–2022. Incoming president is William A. Marston, MD, professor in the department of surgery at the University of North Carolina School of Medicine in Chapel Hill, North…